Recent News

• 04.09.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.09.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.02.2025 - Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
• 04.02.2025 - Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
• 03.21.2025 - Immuneering Corporation Announces Grant of Inducement Award
• 03.21.2025 - Immuneering Corporation Announces Grant of Inducement Award
• 03.20.2025 - Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
• 03.20.2025 - Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
• 03.20.2025 - Immuneering Names Dr. Igor Matushansky as Chief Medical Officer
• 03.20.2025 - Immuneering Names Dr. Igor Matushansky as Chief Medical Officer

Recent Filings

• 03.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 3 Initial statement of beneficial ownership of securities
• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.20.2025 - 8-K Current report
• 03.20.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.20.2025 - EX-99.1 EX-99.1
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities